Global
sustainability banner

 

Did You Know?
The greenest patient is the one whose respiratory health is well-controlled.

greenest asthma

For people with asthma, greenhouse gas emissions are 3x higher when their asthma is uncontrolled.1

greenest hospital

For people who need to be hospitalized with a respiratory exacerbation, the carbon footprint of one overnight stay in the hospital is 125,000g CO2E.2

greenest car

That’s nearly 48x higher than the average daily car trip.3

 

 

 

That's why we put the patient first, always.

Our mission is to help patients around the world breathe better so they can live fuller lives.

We know there's a direct link between respiratory health and air quality.4,5 That's why we're taking meaningful and measured actions to enable positive patient outcomes that significantly reduce our carbon emissions

 

Highlights from our sustainability journey so far

Recipients of the Bronze EcoVadis Medal (2025) 
for sustainability management systems

Ecovadis Badge

 

journey-patients

Patients and Community Partners

  • Devices available to patients in over 110 countries worldwide.6
  • +100,000 subscribers receive education and support through the myAero community.6
  • $28,866 CAD in employee-led, company-matched donations raised by TMI gives in 2024, and granted to local organizations who share our community ethos.6
journey-validation

Product Development and Validation

  • 100% of new products complete a Lifecycle Assessment (LCA) to inform sustainable design decisions, including process emissions, resource consumption, and material choices.6
  • +150 peer-reviewed articles and publications backing product safety and efficacy.6
journey-manufacturing

Manufacturing and Operations

  • 0 water used during our manufacturing process.6
  • 92% of electricity used in our manufacturing process comes from clean energy sources, thanks to Ontario’s predominantly renewable and low-carbon power grid.10
  • Operating a Quality Management System certified to ISO13485:20166

Products

  • Using an AeroChamber* Brand Spacer has been shown to increase mean lung deposition by approximately 2x compared to use of the MDI alone, since it helps overcome challenges with inhaler technique.3 By reducing the number of puffs, side effects and emergency visits, the spacer positively impacts both the patient, environment and healthcare system.11
  • The Aerobika* OPEP Device is clinically-proven to reduce COPD flare-ups by 28% within 30 days of use and significantly reduce the use of oral corticosteroids and antibiotics.8
  • The AeroEclipse* II BAN* Nebulizer has been shown to significantly reduce hospital admissions and emergency department bed hours for asthma and COPD exacerbations. This leads to substantial cost savings and improved operational efficiency for hospitals and health systems.9

Our Sustainability Strategy

As part of the Trudell Medical Group of companies, our business objectives are aligned to the principles of sustainability under a multi-year strategy: Shaping a Sustainable Tomorrow.

This enterprise approach outlines our material priorities – environmental, social, and governance – and our roadmap to achieve them.

Sustainability Resources

1.    Wilkinson A. et al. Greenhouse gas emissions associated with asthma care in the UK: results from SABINA CARBON. Oral session presented at European Respiratory Society (ERS) International Congress, 2021 Sep 5-8.
2.    Tennison et al. Health care’s response to climate change: a carbon footprint assessment of the NHS in England. Lancet Planet Health 2021; 5: e84–92.
3.    Suggett J et al. Assessment of Metered Dose Inhaler (MDI) vs MDI and Spacer-Impact on patient, health care system, and the environment. Pharmacotherapeutics, Vol 164, Issue 4, Supplement A5208, Oct 2023.
4.    Ambient (outdoor) air pollution. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/ambient-(outdoor)-air-…. 2024 Oct 16.
5.    Household air pollution. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/household-air-pollutio…. 2024 Oct 16.
6.    TMI internal data.
7.    LCA Greenstop Solutions Technical report, Feb 2024.
8.    Adapted from Svenningsen S, Paulin GA, Sheikh K, et al. Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease. COPD. 2016;13(1):66-74
9.    Luo et al. Breath-Actuated Nebulizers for Asthma and Chronic Obstructive Pulmonary Disease Exacerbation: A Monte Carlo Simulation Demonstrating National Cost Savings and Length of Stay Reduction. Journal of the American College of Emergency Physicians. 2025;6:100112.
10.    Ontario: Clean electricity snapshot. https://www.canada.ca/en/services/environment/weather/climatechange/cli…. 2022-2024.
11.    Kaplan A et al. AERO CA 01 Survey: Benefits of Valved Holding Chamber Usage on Patients, Healthcare, and the Environment. Canadian Respiratory Conference 2025.